Mercy's Drs. Armando Sardi and Teresa Diaz-Montes Discuss HIPEC as First Line Treatment for Ovarian Cancer

April 23, 2018
Surgical Oncology at Mercy - Baltimore, MD

Ovarian cancer is particularly deadly -- 75 to 80 percent of women are at an advanced stage by the time they're diagnosed, but there's a promising new approach to treatment that's currently under study.

Mercy Medical Center surgical oncologist Dr. Armando Sardi of The Institute for Cancer Care and Mercy gynecologic oncologist Dr. Teresa Diaz-Montes of The Gynecologic Oncology Center at Mercy are teaming up to fight ovarian cancer.

They are part of a study using a technique called Hyperthermic (Heated) Intraperitoneal Chemotherapy, or HIPEC. It's a two-step cancer treatment process. Surgeons first remove the cancer, then immediately administer heated chemotherapy to kill microscopic cancer cells left behind.

"The idea is to combine two specialties, surgical oncology and gynecological oncology to work together to assure all the tumor is removed, which is the most important aspect of the component," Dr. Sardi said.

HIPEC is already used to treat abdominal cancers and the study involving ovarian cancer, which began in Europe four years ago, is promising so far.

"People seem to be living longer, although it's too early to tell," Dr. Sardi said.

In fact, the very first ovarian cancer patient involved in the study is still alive today.

"We're very excited about what we have accomplished. We have that first patient that we did with HIPEC, and she's four years out and she had bad, stage 4 or stage 3, cancer, and she's fine," Dr. Diaz-Montes said.
"It's something that I think could change the life of many women," Dr. Sardi added.

View Dr. Sardi and Dr. Diaz-Montes’ interview regarding HIPEC for ovarian cancer.


Dan Collins - Senior Director of Media Relations at Mercy Medical Center

Dan Collins, Senior Director of Media Relations

Email: dcollins@mdmercy.com Office: 410-332-9714 Cell: 410-375-7342

About Mercy

Founded in 1874 in downtown Baltimore by the Sisters of Mercy, Mercy Medical Center is a 183-licensed bed acute care university-affiliated teaching hospital. Mercy has been recognized as a top Maryland hospital by U.S. News & World Report; a Top 100 hospital for Women’s Health & Orthopedics by Healthgrades; is currently A-rated for Hospital Safety (Leapfrog Group), and is recognized by the American Nurses Credentialing Center as a Magnet Hospital. Mercy Medical Center is part of Mercy Health Services (MHS), the parent of Mercy’s primary care and specialty care physician enterprise, known as Mercy Personal Physicians, which employs more than 200 providers with locations in Baltimore, Lutherville, Overlea, Glen Burnie, Columbia and Reisterstown. For more information about Mercy, visit www.mdmercy.com, MDMercyMedia on FacebookTwitter, or call 1-800-MD-Mercy.

News and Events